The Journey to SDTM and Beyond, New Webinar Hosted by Xtalks
/EINPresswire.com/ -- TORONTO, ON--(Marketwired - October 15, 2015) - On Wednesday, October 21, 2015, join industry experts Richard Davies, Executive Director of Business Solutions at OmniComm Systems, and Ed Chappell, Consultancy Team Lead at Formedix, for an informative one-hour session as they delve into the journey from CDASH to SDTM and beyond.
Key topics include:
- The importance of standardization of eCRFs and datasets
- Creating forms, edit checks and workflow programming to design and build TrialMaster
- Utilizing and re-using standardized trial components in TrialMaster
- Using TrialMaster to map from CDASH to SDTM
- Beyond SDTM: Establishing libraries of SDTM designs and mappings for reuse, source to target traceability reporting, generation of ETL code, and advanced metadata validation
To register or learn more about this complimentary event visit: The Journey to SDTM and Beyond
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx
Image Available: http://www.marketwire.com/library/MwGo/2015/10/14/11G067615/Images/OmniComm_logo(new)_200-568566121653.jpg
_200-568566121653.jpg){kind=link}
Contact:
Dian Razak
Tel: +1 (416) 977-6555 ext 352
Email: drazak@xtalks.com
_200-568566121653.jpg)
OmniComm Systems is a leading strategic software solutions provider to the life sciences industry. OmniComm Systems is dedicated to helping the world's pharmaceutical, biotechnology, CROs, research and medical device organizations maximize the value of their clinical research investments
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
